Shattuck Labs (STTK)
(Delayed Data from NSDQ)
$4.43 USD
+0.12 (2.78%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $4.44 +0.01 (0.23%) 6:42 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Brokerage Reports
0 items in cart
Shattuck Labs, Inc. [STTK]
Reports for Purchase
Showing records 21 - 31 ( 31 total )
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
Gamma Delta T Cell Therapy: A Small (But Mighty) Subset of T Cells Ready for Battle in I/O Space
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
2022 Results; Upcoming Multiple Inflection Points for SL-172154; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
Food for Thought: CD47 Blockade Emerges as a Next- Generation Checkpoint Inhibitor Strategy; Reit. Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
Following a Year of Execution, Three Key Clinical Readouts on the Horizon
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
3Q22 Results; Multiple SL-172154 Readouts on Track During 1H23; GADLEN Update at SITC
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
2Q22 Results; SL-172154 Advances; Phase 1b Study in PROC Expected to Begin Shortly; Multiple Readouts by 1H23
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
Magrolimab Green Light From FDA and ASCO Updates Bode Well for SL-172154
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
BMY Engages Gamma Delta T-cells; We Believe This Bolsters GADLEN Visibility
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
1Q22 Results; Bolstered by Strong Cash Position, Lead Assets Continue Rapid Progress in the Clinic
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
Modular Therapies Packing a Powerful One-Two Punch; Initiating at Buy and $28 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J